IGF1 and cancer: In pancreatic cancer, the ablation of the oncogenic drivers mutant KRAS and c-MYC induces a dormant state, allowing the survival of a few residual cancer cells, which rely on autocrine IGF1/AKT as an adaptive mechanism [51].